Resection Better Than Chemo for Resectable Pancreatic Cancer

Surgical resection (SR) may be better than multiagent chemotherapy (MCT) for resectable pancreatic cancer. Compared with 3,103 patients receiving MCT, those receiving SR had better overall survival at 90 days and three years despite patients in the SR group being older and having more comorbidities.

Via HPB. Published online December 16, 2021.

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ